Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ART FILLER UNIVERSAL is a dermal filler developed by Fillmed Laboratoires, designed for the correction of medium to deep facial wrinkles, restoration of facial volume, and lip augmentation. The product is formulated using proprietary Tri-Hyal® technology, which combines free, long-chain, and very long-chain hyaluronic acid molecules to create a cohesive and viscoelastic gel. This structure allows for high moldability and integration into the skin's extracellular matrix, providing immediate structural support and hydration. Additionally, the formulation contains 0.3% lidocaine hydrochloride, which acts as a local anesthetic to minimize pain during the injection process. It is supplied in pre-filled syringes for professional administration via intradermal or subcutaneous injection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ART FILLER UNIVERSAL.